We report three cases of women with breast cancer who developed renal impai
rment following treatment with high-dose ifosfamide. All the women underwen
t renal biopsy, which demonstrated severe interstitial damage with tubular
changes by light and electron microscopy. Although reversible acute tubular
dysfunction is well recognised with ifosfamide therapy, the long-term outc
ome of ifosfamide-induced renal injury remains unclear. The results of the
current study suggest that ifosfamide can cause severe irreversible renal t
ubulointerstitial injury and should be used with caution even when there is
initially normal renal function.